TLR7 and systemic lupus erythematosus: Mechanistically, miR-146a acts as a negative regulator of type I IFN production by targeting multiple signaling components downstream of TLR7/9 and the retinoic acid-inducible gene-I pathways, thus its downregulated expression in lupus leukocytes promotes IFN-α production [12,13,14].